Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rang in Aktien #28154
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Aktienkurs
$1.40
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$28.25M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
536.36%
Land
IL
Handel Raphael Pharmaceutical Inc. (RAPH)

Kategorie

Aktien-Split-Historie für Raphael Pharmaceutical Inc. (RAPH)
Die Aktie Raphael Pharmaceutical Inc. (Symbol: RAPH) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 20, 2026 statt.
Eine RAPH-Aktie, die vor dem Aug 20, 2026 gekauft wurde, entspricht heute 0 RAPH-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber